Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.

Catheter excursion, inter-lesion distance tied to arrhythmia recurrence after ablation

03 Dec 2019

The spatial instability of the ablation catheter, as well as decreased lesion sequentiality, predict the recurrence of arrhythmia in patients undergoing radiofrequency ablation for paroxysmal atrial fibrillation (AF), a new study has shown.

Researchers enrolled 100 consecutive patients (mean age, 62±11 years; 66 percent male), in whom the spatial position of the ablation catheter was assessed when radiofrequency was being applied at a frequency 60 Hz. The primary study outcome was freedom from atrial arrhythmia for at least 30 seconds after one ablation procedure. Fourteen participants were under continuous implantable monitoring.

There was a total of 14,703 ablation lesions assessed, corresponding to 1,044±525 position data points per lesion. Over 15 million position data points were analysed in total. Kaplan-Meier analysis estimated an 86-percent arrhythmia-free survival rate at the 1-year follow-up.

Patients who experienced recurrence also showed significantly greater mean (1.08±0.13 vs 0.98±0.17 mm; p=0.01) and maximal (3.07±0.38 vs 2.80±0.40 mm; p=0.03) catheter excursion. The same was true for the percentage of lesions with inter-lesion distance >6 mm (53±9 percent vs 46±8 percent; p<0.001).

No such differences were reported for other ablation parameters, such as radiofrequency time, lesion duration, impedance decline and the average power delivered.

Logistic regression analysis further confirmed that having more lesions with >6-mm inter-lesion distance (odds ratio [OR], 1.12, 95 percent confidence interval [CI], 1.04–1.22) was a significant risk factor for recurrence, as was greater excursion (mean: OR, 28.94, 95 percent CI, 1.02–819.17; max: OR, 5.15, 95 percent CI, 1.21–21.90).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.